Charles River

Biosimilars

Since the development and manufacturing of biosimilars can be just as complex as the innovator products, it is important to find a provider that has experience with various types of molecules. As a true end-to-end CRO, Charles River offers the multidisciplinary expertise and capabilities to support our clients’ development of a diverse range of biosimilar drugs.

Biosimilar Drug Product Development

Combining years of experience in the development of biologic products with a deep knowledge of regulatory requirements, we have created a comprehensive program to support our clients’ biosimilar development programs from GMP facilities for performing originator characterization and comparability to in vivo preclinical studies and preclinical and clinical sample analysis through final product lot release.